SV

Street Verdict

Analyst Scorecard

A record of what Jatin Gedia said publicly, with the source. Not advice.

“Bullish on Dr Reddy’s Laboratories Ltd, recommending a buy with a target of ₹1265 and a stop loss at ₹1200 for a short-term trading horizon.”

Jatin Gedia’s track record (trackable calls only): 50 graded calls · 95% CI 22–48%

Dr. Reddy's Laboratories LtdBullishCalled 21 May 2025Graded 05 Jun 2025
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹1,265, stop ₹1,200, as stated.

No time frame is stated, so it is tracked until a close reaches ₹1,265 or ₹1,200: there is no fixed window.

The target ₹1,265 was reached on a close before the stop ₹1,200. Hit.

The grader’s working: R4 TARGET_CALL: entered ₹1222.2 on 2025-05-22 (next trading session's close); target ₹1265 reached at close ₹1290.6 on 2025-06-05. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Dr. Reddy's Laboratories Ltd since this call

1-year tracking window
Read the original articleSee Jatin Gedia’s full track record